Showing results (221-230 of 262) with videos related to

Sort By:
Pageof 27
International Journal of Epidemiology|January 1, 1991
Medical history and the risk of Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research GroupM M Breteler, C M van Duijn, V Chandra, et al.
Journal of Medicinal Chemistry|August 4, 1995
Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cellsM F Boehm, L Zhang, L Zhi, et al.
Nature|October 3, 1996
Activation of specific RXR heterodimers by an antagonist of RXR homodimersD S Lala, R Mukherjee, I G Schulman, et al.
Science (New York, N.Y.)|September 1, 2000
Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimersJ J Repa, S D Turley, J A Lobaccaro, et al.
International Journal of Epidemiology|January 1, 1991
Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research GroupJ A Mortimer, C M van Duijn, V Chandra, et al.
International Journal of Epidemiology|January 1, 1991
Occupational exposures to solvents and lead as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research GroupA B Graves, C M van Duijn, V Chandra, et al.
International Journal of Epidemiology|January 1, 1991
Psychiatric history and related exposures as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research GroupA F Jorm, C M van Duijn, V Chandra, et al.
International Journal of Epidemiology|January 1, 1991
Alcohol and tobacco consumption as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research GroupA B Graves, C M van Duijn, V Chandra, et al.
Cell|May 3, 1996
A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptorsY Kamei, L Xu, T Heinzel, et al.
Neurology|April 1, 1991
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's diseaseS S Mirra, A Heyman, D McKeel, et al.
Pageof 27